Professional Background:

Prof Christoph Hagemeyer is the Director of Monash Biomedical Imaging (MBI) and Head of the NanoBiotechnology Laboratory at Monash’s School of Translational Medicine. He studied Chemistry in Germany and obtained a PhD in Biochemistry from the University of Freiburg (Germany) for contributions to the field of Cytochrome P450 metabolism in the brain. As a postdoctoral fellow, he worked in the field of Magnetic Resonance Imaging (MRI) at the “Centre national de la recherche scientifique” in Bordeaux (France) before migrating to Australia in 2005. He has extensive expertise vascular biology, molecular imaging, recombinant antibodies, and nanotechnology and has been supported throughout his career by national and international fellowships and grants. 

Research Interests:

The Hagemeyer Lab has particular expertise in the use of small recombinant single-chain antibodies for molecular imaging and drug delivery. The group has published widely in leading journals (Circ Res, Adv Mater, Angew Chem..) on cardiovascular research developing anti-thrombotic fusion proteins and novel imaging probes for MRI, Ultrasound and Positron Emission Tomography. The lab has been supported by NHMRC, ARC, and JDRF grants as well as several other grants in competitive schemes.